Renaissance Technologies
ALLR

Renaissance Technologies’s Allarity Therapeutics ALLR Stock Holding History

Renaissance Technologies’s Portfolio ALLR Stock Details ALLR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$428K Buy
331,509
+103,425
+45% +$147K ﹤0.01% 2659
2026
Q1 		$249K Sell
228,084
-19,528
-8% -$21K ﹤0.01% 2863
2025
Q4 		$267K Buy
247,612
+181,426
+274% +$231K ﹤0.01% 2802
2025
Q3 		$105K Buy
+66,186
New +$83.1K ﹤0.01% 3242
2023
Q1 		– Hold
0
– -$11K – 3939
2022
Q4 		– Hold
0
– – – 4028
2022
Q3 		– Hold
0
– – – 3853
2022
Q2 		– Hold
0
– – – 3813
2022
Q1 		– Hold
0
– – – 3586

Other funds holding ALLR

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MCM
Militia Capital Management Austin, Texas $3.37B AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Renaissance Technologies's ALLR Position: Q2 2026 in Review

Renaissance Technologies increased its Allarity Therapeutics (ALLR) stake by 45% in Q2 2026, buying an estimated $147K and bringing the position to 331,509 shares worth $428K. The position accounts for ﹤0.01% of the portfolio, ranked #2659.

Renaissance Technologies first reported a position in ALLR in Q3 2025 and has held it in 4 quarters since. 20 funds tracked by Wall St. Rank hold ALLR as of Q2 2026.

  • Renaissance Technologies held 331,509 shares of Allarity Therapeutics worth $428K as of Q2 2026.
  • Renaissance Technologies bought 103,425 Allarity Therapeutics shares in Q2 2026, an estimated $147K.
  • Allarity Therapeutics made up ﹤0.01% of Renaissance Technologies's portfolio in Q2 2026, its #2659 holding.
  • Renaissance Technologies first reported a position in Allarity Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • 20 funds tracked by Wall St. Rank held Allarity Therapeutics as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.